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Abstract
Fuzi (aconite, Radix Aconiti praeparata), a widely
used Chinese herb, plays a significant role in the
cardiovascular system. This is mainly reflected by
Fuzi's cardiotonic effect, its protective effect on
myocardial cells, and its effect on heart rate and
rhythm, blood pressure, and hemodynamics. In this
article, the pharmacological effects and the corre-
sponding mechanisms of Fuzi (aconite) and its ac-
tive components on cardiovascular system are re-
viewed.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Fuzi (aconite, Radix Aconiti praeparata) is the pro-
cessed tuberous root of Aconitum carmichaeli Debx
(Ranunculaceae). Fuzi tastes spicy and sweet, has a hot
nature and toxicity, acts on the heart, kidney and
spleen meridians and plays a role in saving yang for the
treatment of collapse, supplementing kidney yang, and
eliminating cold to stop pain. Fuzi (aconite) consists of
a variety of alkaloids, such as the diester-diterpene alka-
loids, aconitine, hypaconitine, mesaconitine, and hige-
namine. Aconite also is composed of some lipids, such
as fatty acids, phosphatidate calcium, and steroids. It is
mainly clinically used for treatment of heart failure,
shock and hypotension subsequent to acute myocardial
infarction, coronary heart disease and rheumatic heart
disease. Along with the repeated application of aconite
in clinical practice and studies on pharmacology, its use
in the cardiovascular system has been the focus of in-
creasing research. In this article, aconite's pharmacolog-
ical effects on the cardiovascular system are summa-
rized.
CARDIOTONIC EFFECT OF ACONITE
Domestic and international research has shown that ac-
onite enhances cardiac contractility and also accelerates
myocardial contraction frequency. Rao performed ex-
periments on the heart of toads, frogs, guinea pigs and
rabbits in vitro, and showed a cardiotonic effect of aco-
nite decoction, while experiments on the heart of frogs,
cats, and dogs in vivo also suggested a mildly cardioton-
ic effect of aconite. The mechanism of this action of ac-
onite was shown to be related to calcium based on fur-
ther research.1
Zuo et al. confirmed a "faint pulse verging on expiry"
in a pathological cat model where intravenous adminis-
tration of aconite water extract could gradually en-
hance the heart beat. They observed that the heart in
this cat model contracted more vigorously with much
greater amplitude than that before drug administra-
tion, and repeated administration of the drug resulted
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in a stronger effect. However, this effect was different
according to the different states in the model. For ex-
ample, when the heart beat was weak and the extremi-
ties were cold, aconite had a positive effect, but it did
not show any cardiotonic function when the heart beat
was normal. Further experiments indicated that the
mechanism of effect of aconite may be related to β1 re-
ceptor and α receptor activation in the heart.2
Xu et al.3 reported that aconite decoction can antago-
nize the inhibition of phenobarbital, chloral hydrate
and other drugs on the heart of the toad, and it
showed a significant cardiotonic effect on the heart of
the reserpinized cat model in vivo or in vitro. They con-
cluded that the cardiotonic effect of drugs of this type
is not caused by catecholamine release, but by a direct
contribution on the heart.
Therefore, based on previous findings, aconite has obvi-
ous cardiotonic effects on the heart in vitro and in vi-
vo, as well as in the normal and exhausted heart. The
effective components of aconite include higenamine,
salsoline, methyl chloride dopamine, and aconite glyco-
sides,3~6 and it is likely that there are other undiscov-
ered components.
With regard to the mechanism of the cardiotonic effect
of aconite, different explanations have been provided.
Aconite achieve this effect through some substances
contained in it functions as α receptor and β receptor
agonists, and increases intracellular calcium concentra-
tions by activating sodium channels and increasing Na +
influx, thereby stimulating reverse Na+/Ca2+ exchange.1,2,7
A slight decrease in serumTumor Necrosis Factor –α
(TNF-α) and Nitric oxide (NO) levels of adriamy-
cin-induced heart failure in rats by aconite decoction
has been shown, suggesting another mechanism of car-
diotonic function.8
Aconite is widely used in the treatment of heart failure
and shock subsequent to acute myocardial infarction,
especially for symptoms, such as yang debilitation, a
cold body and extremities, and a faint pulse verging on
expiry, which also suggest that aconite has cardiotonic
and anti-shock effects. Although the purified chemical
composition from Fuzi has strong cardiotonic and an-
ti-shock effects, the herb, Fuzi, itself hasn't been used
as a cardiotonic drug in research and in the clinical set-
ting. This may be because of the effect of one the
herb's ingredients, aconitine, which can cause rapid ar-
rhythmia and ventricular fibrillation.
PROTECTIVE EFFECT OF ACONITE
ONMYOCARDIAL CELLS
It has previously been shown that aconite and its ex-
tract can conserve myocardial cells of animal models
and clinical patients with heart failure, myocardial in-
farction, cardiac hypertrophy and other cardiovascular
diseases. The explanation of the mechanism of action
varies because of different viewpoints.
Huang et al studied a rat model of heart failure in-
duced by adriamycin, and found that aconite decoc-
tion could reduce Brain natriuretic peptide and Inter-
leukin-6 levels in serum, protect blood vessels and
myocardial cells, and improve heart function. They al-
so showed that the degree of myocardial cell injury was
significantly less in the aconite decoction group than
that in the heart failure model group which was not
given any drug after the heart failure model is success-
fully made.9 Fang, et al reported that hypaconitine at
an appropriate concentration of 250 ng/mL reduces
apoptosis of myocardial cells induced by H2O2. They
speculated that its mechanism may be related to a de-
crease in expression of the apoptosis proteins, caspases
3 and 9, and an increase in cell proliferation activity.10
Lee et al showed that higenamine protects myocardial
cells from ischemia reperfusion injury, and therefore, it
significantly reduces myocardial infarct size. They
found that administration of higenamine 1 hour prior
to ischemic-reperfusion (I/R)-injury greatly decreased
the release of cytochrome C, caspase-3 activity, and
Bax expression, but it up-regulated the expression of
Bcl-2 and HO-1, as well as HO enzyme activity in the
left ventricle. These changes could be inhibited by
ZnPP IX, an enzyme inhibitor of HO-1. As a result,
they considered that HO-1 plays an important role in
the protective action of higenamine in I/R-induced
myocardial injury.11
It has also been suggested that the mechanism of the
above function may be due to blocking sodium chan-
nels,12 or protecting the mitochondria of the cells.13 A
previous study investigated the effect of aconite on the
vascular extracellular matrix of the aorta in a cardiac hy-
pertrophy rat model induced by thyroxine, and found
that the mechanism whereby aconite prevented cardio-
vascular hypertrophy could be attributed to inhibition
of collagen synthesis.14
Combined administration with ginger in a heart failure
model in the rat, aconite causes a decrease in the epi-
nephrine, atrial natriuretic peptide, and endothelin lev-
els in plasma. Furthermore, on the one hand, a de-
crease in epinephrine levels can prevent or reduce the
toxicity of catecholamines on the heart, reduce myocar-
dial energy demand and curb excessive adrenergic de-
compensation during heart failure, and on the other
hand, a decrease in epinephrine levels can also inhibit
renin release.15
In addition, the active ingredients of aconite have an-
ti-inflammatory and antioxidant effects, which both
play important roles in a variety of cardiovascular dis-
eases. For example, an increased expression of adhesion
molecules and inflammatory-induced cytokines was
found in the myocardial tissues of patients with cardio-
vascular disease, indicating that local inflammation of
microvascular and myocardial cells is important in the
pathological changes of cardiovascular diseases.16~18 This
also provides a theoretical basis for the protective effect
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of aconite on myocardial cells.
The effect of Yi Qi Wen Yang Huo Xue Fang (tonify
Qi, warm yang, and promote blood circulation formu-
la) on bone marrow stem cells in patients with myocar-
dial infarction was investigated, and it was found that
it can mobilize stem cells, which can reduce myocardial
infarct size, suppress left ventricular remodeling, and
improve cardiac function.19
As well as the protective effect of aconite on myocardi-
al cells, including inhibiting injury of these cells, it can
also mobilize bone marrow stem cells that may migrate
into the ischemic myocardium, differentiate into myo-
cardial cells in the myocardial microenvironment to in-
crease the number of myocardial cells directly, and alter
necrosis of the myocardium.
EFFECT OF ACONITE ON HEART
RATE AND RHYTHM
Aconite can increase heart rate, mentioned as positive
chronotropic action, and it also acts on the rhythm of
the heart, which antagonizes arrhythmia and results in
an arrhythmogenic effect. This may lie in the fact that
different components of aconite have different pharma-
cological effects. The effects of aconite on heart rate
and rhythm vary between studies because of different
origins, processing methods, extract compositions, ani-
mal models, and how individual body reacts upon spe-
cial circumstances. An aconite decoction can speed up
the contraction frequency of the mammalian heart in
vitro. However, a large dose of aconite inhibits the
heart by slowing the heart rate, which suggests that the
effect of aconite on heart rate is dose-related.1 Another
study reported that an aqueous solution of aconite in
different doses can accelerate the heart rate in a cat
model of heart failure, but it did not significantly affect
the heart rate of normal anesthetized dogs and cats.6
Zhang, et al. showed that butanol extract, ethanol ex-
tract and aqueous extract of aconite all have a preven-
tive effect on ventricular fibrillation induced by chloro-
form in mice, especially the aqueous extract.20 Wang et
al. administrated hypaconitine intravenously to anes-
thetized rats and observed its effect on electrocardio-
gram and experimental arrhythmia. They found that a
small dose (0.5 mg·kg-1 intraperitoneal injection) of
hypaconitine caused anti-arrhythmic effects. Hypaconi-
tine could antagonize aconitine-induced arrhythmia.
Therefore, hypaconitine serves as a natural compound
type I anti-arrhythmic.21
With regard to the mechanism, it could be related to
higenamine up regulating the Adrenergic beta-receptor
(β-AR)22,23 and electrophysiological properties and ion
channels of myocardial cell membranes.12 A previous
study suggested that higenamine increases the respon-
sivity of cAMP in plasma, and affects heart rate
through the receptor-G protein-cAMP complex.22
Large doses of higenamine act directly on the β-AR,
showing neither synergy nor antagonism with isopro-
terenol (ISO), suggesting that its up-regulation of myo-
cardial β-AR function may also achieved by affecting
the pharmacokinetics of the receptor, subtypes chang-
es, and gene expression.23 Ameri reported that anti-ar-
rhythmia may depend on chemical composition of
Fuzi (aconite) having different affinities to various sub-
types of the alpha-subunit of the Na + channel in the
brain and heart.24
The dual pharmacological effect of aconite and its ex-
tract on heart rate and rhythm determines its different
clinical applications. According to the effect of hige-
namine on bradyarrhythmia, it is clinically used to
treat sinus bradycardia, sinoatrial block and atrioven-
tricular block, with satisfactory results. Guanfu base A,
an active extract ingredient from white aconite, has
shown great value in antagonizing supraventricular ar-
rhythmia, improving myocardial ischemia and anti-an-
gina.
In spite of the antiarrhythmic effect of aconite, it is al-
so reported that aconite can induce arrhythmia, in
which ventricular arrhythmia, sinus tachycardia or bra-
dycardia are common,25,26 but bundle branch block is
rare.27 Aconite is often used to create anti-arrhythmic
animal models in research because of its arrhythmogen-
ic pharmacological property.28
Diterpenoid alkaloids contained in aconite can induce
arrhythmia. Two mechanisms are involved: 1) they
have a direct effect on the myocardium causing sodium
ion channels in the myocardial cells to open, accelerat-
ing the influx of sodium ions, leading to membrane de-
polarization, increasing automaticity of fast responsive
cells, and leading to arrhythmia; and 2) they cause va-
gus nerve stimulation, resulting in arrhythmia, such as
bradycardia.29
EFFECT OF ACONITE ON BLOOD
PRESSURE
Reports of aconite's effects on blood pressure are var-
ied, including some reports that it lowers blood pres-
sure, some studies have shown that it elevates blood
pressure initially and then lowers blood pressure later,
and some studies consider that it has no significant ef-
fect on blood pressure.3 The reason for this discrepancy
between studies may be because blood pressure-increas-
ing substances, such as chloride methyldopamine and
salsolinol, and blood pressure-decreasing substances,
such as higenamine, coexist in aconite. Therefore, dif-
ferent origins and processing methods of aconite may
lead to different levels of these components, which
then results in varied effects on blood pressure. In addi-
tion, aconite's effect on blood pressure is also related to
dose.
Gu et al.30 reported the effect of water extract from Si-
chuan aconite on blood pressure of anesthetized cats.
They found that it decreased Blood Pressure (BP) at a
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low dose (12.5-50 mg/kg), but showed a three-phase ef-
fect at a higher dose(400 mg/kg), with a temporary in-
crease in BP, then an immediate increase in BP, fol-
lowed by a final decrease in BP. The mechanism is as
follows: the effect of increasing BP depends on the di-
rect excitement of α receptors in blood vessels; and the
effect of decreasing BP is related to excitement of M re-
ceptors and β2 receptors. Furthermore the effects of ac-
onite on BP also indicates the involvement of nervous
system, as well as unknown active substances of the car-
diovascular system contained in aconite preparations.
The water soluble part of aconite can increase femoral
arterial blood flow, decrease the pressure of blood ves-
sels, and show mild expansion of coronary vessels.6
Chong et al.31 created a vasoconstriction model of rats
using phenylephrine or KCl, and they observed a relax-
ing effect on rat aorta from aconitine, and additionally
found that the relaxing effect was concentration-depen-
dent. Niu et al.32 found that the relaxing effect of aco-
nite decoction on aorta is endothelium-dependent, and
related to NO released by the endothelium, instead of
receptor-dependent Ca2+ channels in cell membranes of
smooth muscle or voltage-dependent Ca2 + . Results of
these experiments showed that aconite had a dilatory
effect on peripheral blood vessels, and its decoction can
significantly expand blood vessels of the hind limb in
anesthetized dogs and cats, and increase blood flow.Af-
ter intravenous administration of aconite, BP of the
"faint pulse verging on expiry" pathological model cat
rose, but this function was significantly weakened byα-receptor blockers. According to the above results, ac-
onite may play a role in the increase of BP as an α re-
ceptor stimulant.2
EFFECTS OF ACONITE ON
HEMODYNAMICS
The effect of aconite on hemodynamics is mainly due
to anticoagulant and anti-thrombosis effects, and the
active component is mainly higenamine. Aconite has
shown therapeutic potential for disseminated intravas-
cular coagulation (DIC) and/or accompanying multi-
ple organ failure. Studies have shown that aconite de-
coction can extend the time for thrombosis, which in-
dicates that it can inhibit blood clotting and antago-
nize thrombosis.33 Higenamine shows inhibitory activi-
ty in both human and rat platelet aggregation induced
by ADP, collagen and epinephrine. And higenamine
had the strongest inhibitory effect on epinephrine-in-
duced aggregation. Anti-thrombotic effects of hige-
namine have also been observed in both an acute
mouse thrombosis model and rat arterio-venous shunt
(AV-shunt) model. The oral administration of hige-
namine increases the rate of recovery from an acute
thrombotic challenge in mice and decreases the weight
of thrombus formed inside the AV-shunt tube in rats.34
Higenamine possibly exerts antithrombotic effects by
blocking α2-adrenergic receptors.35 Higenamine has in-
hibitory effects on amino acid (AA)-induced platelet
aggregation, partly by inhibiting the production of
thromboxane A2 from AA, and partly by directly
blocking the thromboxane A2 receptor, in addition to
previously reported effects on the α2-adrenergic recep-
tor, mostly by directly blocking the thromboxane A2
receptor.36
The effect of higenamine on DIC was investigated by
using an experimental DIC rat model. The oral admin-
istration of higenamine significantly ameliorated a de-
crease in fibrinogen levels in plasma, an increase in fi-
brinogen/fibrin degradation product levels, and prolon-
gation of prothrombin time induced by the intrave-
nous infusion of lipopolysaccharide (LPS). Prolonga-
tion of activated partial thrombin time and a decrease
in platelet count were also suppressed with hige-
namine. Additionally, an increase in serum aspartate
transaminaseand blood urea nitrogen levels was pre-
vented with higenamine.37 These data strongly suggest
that higenamine suppresses NO products and induced
nitric oxide synthase expression in the experimental
DIC model, prevents platelet aggregation, inhibits the
formation of intravascular fibrin deposition or throm-
bosis, and improves blood supply to organs. This indi-
cates that aconitine can protect the heart, platelets and
vascular smooth muscle in the DIC rat model induced
by LPS.38 Previous studies have shown that higenamine
up-regulates the β-AR, increases responsivity of cAMP
in plasma, and acts directly on the β-AR at a large
dose.23
In addition, aconite polyose extracted from aconite in-
creases hepatic low density lipoprotein receptor and cy-
tochrome P450 7alpha-1expression and decreases 3-hy-
droxy-3-methyl glutaryl (HMG)-CoA expression, and
lowers cholesterol levels,39 which are significant factors
in the prevention of cardiovascular diseases.
In conclusion, aconite has been used for the treatment
of many types of diseases, and is especially well known
for its pharmacological effects on the cardiovascular sys-
tem, such as improving heart function, easing ischemia
reperfusion injury, resisting arrhythmia, stretching of
the arteria coronaria, stabilizing blood pressure, and an-
tagonizing coagulation and thrombosis. These effects
are able to be used to treat heart failure, shock due to
myocardial infarcts, arrhythmia, DIC state and multi-
ple organ failure.
However, most of the pharmacological effects of aco-
nite are dual, such as the effects on cardiac rhythm and
blood pressure, which are closely related to the various
active components contained in Chinese herbs. The ba-
sis of the above-mentioned pharmacological effects of
aconite are mostly concerned with the regulation of the
neuroendocrine system. For example, aconite acts as an
agonist of different subtypes of α and β receptors, as
well as affects sodium and calcium ion channels. Fur-
thermore, studies on signal transduction involving NO
311
JTCM |www. journaltcm. com September 15, 2012 |volume 32 | Issue 3 |
Zhao DD et al. Pharmacological effects of Fuzi on cardiovascular system
and cAMP are also carried out supplementarily.
By reviewing the literature in this field, we realized that
the following two points should be emphasized. First,
because of the close relationship between the pharma-
cological effects of aconite and the category and dosage
of the active components, it is unwise to prescribe aco-
nite alone in clinical application with a large dose. It is
highly recommended that aconite is applied when com-
patible with other herbs, such as ginseng, ginger, ramu-
lus cinnamomi, atractylodes macrocephala, tuckahoe,
gypsum, and berberine, to ensure clinical safety, and
play an efficient role in its pharmacological effects. If a
high dose of aconite is required, attention should be
paid to observing adverse reactions, so that any adverse
effects can be dealt with in a timely manner. Other-
wise, it is a good choice to use an extract of an effective
monomer aimed at the corresponding pathological re-
sponse. Second, research on cardiac protection of aco-
nite is still insufficient. Development of science and
technology, in particular, intervention technologies,
has led to an increasing number of patients surviving
from myocardial infarction, which leads to another
problem of ischemia reperfusion injury. As a result, fur-
ther research on the protective effect and application of
aconite on myocardial cells and bone marrow stem cell
mobilization is required, because it can protect myocar-
dial cells from direct injury, while promoting cardiac
cell regeneration.
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